LCGC International's "LC Troubleshooting" column editor Dwight Stoll and colleagues pay tribute to the late Peter Carr, an ...
Franzen wants to move DuPont from the materials sector, where it is considered a specialty chemicals company, to somewhere in ...
A phase II open-label study of enfortumab vedotin in patients with previously treated locally advanced, recurrent, or metastatic pancreatic adenocarcinoma (EPIC). This is an ASCO Meeting Abstract from ...
AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss wins, despite remaining tight-lipped on how the candidate actually performed. The U.K.-based Big ...
Humble brag: I reckon I could spot a fitness gimmick a mile off. As WH’s Fitness Editor, I spend pretty much all day everyday reading/writing about the latest workout trends. I’m also kind of addicted ...
Our research found that Bread Financial’s 2-year CD is one of the best 2-year CDs currently available, earning a 4.4-star rating from our research team. The account earns a solid APY, compounds ...
We're nearing the end of The Multiverse Saga as the final Phase of it, Phase 6, started in July 2025 with The Fantastic Four: First Steps. There's still plenty to enjoy though before it all ends, ...
Rahul Nambiampurath has been writing and reporting about cryptocurrency since 2017. As a fan of decentralized tech, he was fascinated by the Bitcoin whitepaper. Erika Rasure is globally-recognized as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results